Buccal film – Based Drug Delivery: A Promising Platform for Poorly Soluble Phytoconstituents
International Journal of Drug Delivery Technology · 08.06.2026 · 16 (47s)
DOI: 10.25258/ijddt.16.47s.81 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.06.2026. Verfasst von Anuja More und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Transmucosal drug delivery including buccal, sublingual, nasal, rectal, and vaginal routes offers an effective alternative for administering medications. Among these, oral transmucosal delivery is particularly practical because it is convenient, efficient, and easily accessible. Despite these advantages, most products currently available on the market are limited to tablets and films, even though a wide range of formulation strategies exists and the buccal and sublingual routes present significant untapped potential. Compared with traditional oral and injectable dosage forms, drug delivery through the buccal mucosa provides several long-term benefits, such as enhanced bioavailability and reduced risk of systemic side effects, making it a promising option for controlled drug administration. Poor aqueous solubility and extensive first-pass metabolism significantly limit the therapeutic effectiveness of many phytoconstituents when administered through conventional oral dosage forms. Buccal drug delivery has emerged as a promising alternative strategy to overcome these challenges by enabling direct absorption through the oral mucosa and bypassing hepatic first-pass metabolism. Buccal films, in particular, offer several advantages such as prolonged residence time, improved patient compliance, ease of administration, and the potential for controlled drug release. Incorporating poorly soluble phytoconstituents into buccal films can enhance their solubility, dissolution rate, and bioavailability through the use of suitable polymers, permeation enhancers, and formulation techniques. This approach not only improves therapeutic efficacy but also minimizes doserelated systemic side effects. The present work highlights the potential of buccal film-based delivery systems as an effective platform for improving the clinical performance of poorly soluble phytoconstituents and supports their application as a viable alternative to conventional oral formulations.
Zitieren
APA
More, A., Mane, M., Deshmukh, A., Kharmate, S., Joshi, S., Jagdale, S., & Kamble, O. (2026). Buccal film – Based Drug Delivery: A Promising Platform for Poorly Soluble Phytoconstituents. International Journal of Drug Delivery Technology, 16(47s). https://doi.org/10.25258/ijddt.16.47s.81
Vancouver
More A, Mane M, Deshmukh A, Kharmate S, Joshi S, Jagdale S, et al. Buccal film – Based Drug Delivery: A Promising Platform for Poorly Soluble Phytoconstituents. International Journal of Drug Delivery Technology. 2026;16(47s). doi:10.25258/ijddt.16.47s.81
BibTeX
@article{More2026,
author = {More, Anuja and Mane, Manisha and Deshmukh, Akshada and Kharmate, Shrirang and Joshi, Saurabh and Jagdale, Satyajeet and Kamble, Omkar},
title = {Buccal film – Based Drug Delivery: A Promising Platform for Poorly Soluble Phytoconstituents},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {47s},
doi = {10.25258/ijddt.16.47s.81}
}
EUVIMED